Drug Safety of Celecoxib

Journal Title: International Journal of Medical Research and Review - Year 2016, Vol 4, Issue 10

Abstract

Introduction: Non-steroidal anti-inflammatory drugs presently are the most widely used drugs in medicine and are the most frequent cause of adverse drug reactions, affecting multiple systems, mainly gastric, renal & cardiovascular, which is a major public health concern. Previous studies report, that selective COX-2 inhibitors are safer when compared to non-selective cyclooxygenase inhibitors. But, recent studies reveal, that the safety of these selective COX-2 inhibitors is not much better than that of conventional NSAIDs. In view of the wider usage of selective COX-2 inhibitor, celecoxib in day to day practice by many clinicians, the study has been taken up to report, whether selective COX-2 inhibitor celecoxib has got any advantages over conventional NSAIDs or not. Methodology: 15 patients were taken up for the study & all the patients were given celecoxib for 15 days. Both pre and post-treatment values of Hb%, blood urea, serum creatinine, serum bilirubin, bleeding time, clotting time, heart rate & blood pressure were recorded, tabulated & subjected to statistical analysis. Results: Selective COX-2 inhibitor, celecoxib has shown significant changes in bleeding time values & also good amount of gastric toxicity when assessed clinically. Hepatic, renal & other cardiovascular parameters were absolutely normal. Conclusion: In our short-term study, selective COX-2 inhibitor, celecoxib has shown good amount of gastric toxicity, showing no advantage over non-selective drugs. But, there is no hepatic, renal & cardiovascular toxicity.

Authors and Affiliations

K. Hima Bindu, G. Venkat Rao

Keywords

Related Articles

Unusual presentation of interrupted aortic arch: a case report and radiological review

Interrupted aortic arch, a rare congenital malformation and there is a loss of luminal continuity between the ascending and descending portions of the aortic arch. Their incidences are of 3 per million live births and ma...

A comparison of platelet parameters in type-2 diabetics, pre-diabetics and normal subjects

Introduction: Diabetes Mellitus is a global pandemic disease. The increased platelet activity is emphasized to play a role in the development of vascular complications of the metabolic disorder. Mean platelet volume (MPV...

Giant cell tumour of dorsal spine presenting with mediastinal mass: a rare case report

Incidence of giant cell tumour (GCT) of spine above sacrum is rare. Moreover, involvement of posterior elements of spine is a rare entity. Furthermore, primary GCT arising at thoracic spine presenting as a huge mediastin...

Laparoscopic transabdominal preperitoneal versus open mesh lichtenstein repair of inguinal hernia: a comparative analysis

Background: Inguinal hernia repair is a commonly performed surgery usually managed by open surgical mesh repair. Nowadays many patients are demanding laparoscopic hernia repair. Laparoscopic hernioplasty has a shorter re...

Comparison of conventional methods with gene xpert mtb/rif assay for rapid detection of mycobacterium tuberculosis and rifampicin resistance in extra-pulmonary samples

Introduction: Tuberculosis (TB) is a major health problem in India. The World Health Organization has recently in 2010 endorsed the Gene Xpert MTB/RIF assay for rapid detection of smear negative and multidrug resistance...

Download PDF file
  • EP ID EP231467
  • DOI 10.17511
  • Views 136
  • Downloads 0

How To Cite

K. Hima Bindu, G. Venkat Rao (2016). Drug Safety of Celecoxib. International Journal of Medical Research and Review, 4(10), 1796-1801. https://europub.co.uk/articles/-A-231467